**Core Concept**
HIV-1 transmission across the placenta during pregnancy is a significant concern for mother-to-child transmission (MTCT) of the virus. This process involves the passage of HIV-1 from the maternal bloodstream into the fetal circulation, leading to infection.

**Why the Correct Answer is Right**
HIV-1 transmission across the placenta occurs through the rupture of syncytiotrophoblasts, which form the placental barrier. This rupture allows HIV-1 to penetrate the placenta and enter the fetal circulation. The virus then infects the fetal cells, including CD4+ T lymphocytes, which are the primary targets of HIV-1. The mechanism of transplacental transmission is similar to that of HIV-1 entry into host cells, involving the interaction of the viral envelope glycoprotein (gp120) with the host CD4 receptor and co-receptors (CCR5 or CXCR4).

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not provided, please fill in the correct options.
**Option B:** This option is not provided, please fill in the correct options.
**Option C:** This option is not provided, please fill in the correct options.
**Option D:** This option is not provided, please fill in the correct options.

**Clinical Pearl / High-Yield Fact**
To minimize the risk of MTCT, pregnant women with HIV-1 should receive antiretroviral therapy (ART) to suppress viral replication and prevent further transmission. ART regimens that include a combination of nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), or protease inhibitors (PIs) have been shown to effectively reduce the risk of MTCT.

**Correct Answer:** D.